Actively Recruiting
HIBA-Institutional Registry of Amyloidosis
Led by Hospital Italiano de Buenos Aires · Updated on 2026-01-22
500
Participants Needed
1
Research Sites
978 weeks
Total Duration
On this page
Sponsors
H
Hospital Italiano de Buenos Aires
Lead Sponsor
I
Instituto Cardiovascular de Buenos Aires
Collaborating Sponsor
AI-Summary
What this Trial Is About
1. Creating a population-based registry system Amyloidosis prospective epidemiological survey * risk factors * diagnosis * prognosis * treatment * monitoring * survival 2. Describe the occurrence of amyloidosis in the population of HIBA, Hospital Italiano de Buenos Aires. 3. Describe the characteristics of clinical presentation, evolution and predisposing factors of amyloidosis.
CONDITIONS
Official Title
HIBA-Institutional Registry of Amyloidosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 years or older
- Confirmed amyloidosis by tissue biopsy in abdominal fat, bone marrow, rectum, or affected organ (e.g., kidney, liver, sural nerve)
- Clinically compatible cases of amyloidosis identified by relevant diagnostic tests or clinical evaluation
You will not qualify if you...
- Refusal to participate or provide informed consent by the patient or legal representative
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital Italiano de Buenos Aires
Buenos Aires, Buenos Aires, Argentina, C1199
Actively Recruiting
Research Team
M
María L Posadas-Martínez, MD, PhD
CONTACT
A
Adela Aguirre, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here